The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Who Are Medical Marijuana Patients? Population Characteristics from Nine California Assessment Clinics
Abstract
Marijuana is a currently illegal psychoactive drug that many physicians believe has substantial therapeutic uses. The medical literature contains a growing number of studies on cannabinoids as well as case studies and anecdotal reports suggesting therapeutic potential. Fifteen states have passed medical marijuana laws, but little is known about the growing population of patients who use marijuana medicinally. This article reports on a sample of 1,746 patients from a network of nine medical marijuana evaluation clinics in California. Patients completed a standardized medical history form; evaluating physicians completed standardized evaluation forms. From this data we describe patient characteristics, self-reported presenting symptoms, physician evaluations, other treatments tried, other drug use, and medical marijuana use practices. Pain, insomnia, and anxiety were the most common conditions for which evaluating physicians recommended medical marijuana. Shifts in the medical marijuana patient population over time, the need for further research, and the issue of diversion are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
Expenditures and health status among adults with back and neck problems
Martin, B. I. (2008) · JAMA · doi:10.1001/jama.299.6.656 · Cited by 1,531 · cited 2×
“3% increase in the prevalence of spine problems between 1997 and 2005 (Martin et al. 2008).”
InfluentialResults From the 2008 National Survey on Drug Use and Health: National Findings: (592592009-001)
(2009) · PsycEXTRA Dataset · doi:10.1037/e592592009-001 · Cited by 1,176
Trends in Opioid Prescribing by Race/Ethnicity for Patients Seeking Care in US Emergency Departments
Pletcher, M. J., Kertesz, S. G., Kohn, M. A., & Gonzales, R. (2008) · JAMA · doi:10.1001/jama.2007.64 · Cited by 827
McSherry, B., & Duke, J. (1999) · Cited by 743
Crack in America: Demon Drugs and Social Justice
Covington, J., Reinarman, C., & Levine, H. (1998) · Contemporary Sociology · doi:10.2307/2655222 · Cited by 541
Self-citationBrecher, E. M. (1972) · Cited by 526
Price, E. (1980) · Cited by 302
Cannabis and cannabinoids: pharmacology, toxicology, and therapeutic potential
(2003) · Choice Reviews Online · doi:10.5860/choice.40-3432 · Cited by 293
Hashibe, M., Morgenstern, H., Cui, Y., Tashkin, D. P., Zhang, Z.-F., Cozen, W., Mack, T. M., & Greenland, S. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0330 · Cited by 256
Cited by
US epidemiology of cannabis use and associated problems
Hasin, D. S. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.198 · Cited by 578
The Pharmacologic and Clinical Effects of Medical Cannabis
Borgelt, L. M., Franson, K. L., Nussbaum, A. M., & Wang, G. S. (2013) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1187 · Cited by 423
Evaluating the public health impacts of legalizing recreational cannabis use in the United States
Hall, W., & Lynskey, M. (2016) · Addiction · doi:10.1111/add.13428 · Cited by 357
Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use
Walsh, Z., Callaway, R., Belle-Isle, L., Capler, R., Kay, R., Lucas, P., & Holtzman, S. (2013) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2013.08.010 · Cited by 347
Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D
Bradford, A. C., & Bradford, W. D. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1661 · Cited by 341
A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy
Sexton, M., Cuttler, C., Finnell, J. S., & Mischley, L. K. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2016.0007 · Cited by 336
Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain
Wilsey, B., Marcotte, T., Deutsch, R., Gouaux, B., Sakai, S., & Donaghe, H. (2013) · The Journal of Pain · doi:10.1016/j.jpain.2012.10.009 · Cited by 314
“3%).(50) There being no information as to the concentration of cannabis consumed by those surveyed, it is not feasible to provide any insight whether those medicinal cannabis patients were receiving low or high concentrations of THC.”
Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users
Bonn-Miller, M. O., Boden, M. T., Bucossi, M. M., & Babson, K. A. (2014) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2013.821477 · Cited by 281
Blurred Boundaries: The Therapeutics and Politics of Medical Marijuana
Bostwick, J. M. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2011.10.003 · Cited by 261
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
Sarris, J., Sinclair, J., Karamacoska, D., Davidson, M., & Firth, J. (2020) · BMC Psychiatry · doi:10.1186/s12888-019-2409-8 · Cited by 253
Cannabis and mental illness: a review
Lowe, D. J. E., Sasiadek, J. D., Coles, A. S., & George, T. P. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0970-7 · Cited by 253
Cannabis as a substitute for prescription drugs – a cross-sectional study
Corroon, J., Mischley, L., & Sexton, M. (2017) · Journal of Pain Research · doi:10.2147/jpr.s134330 · Cited by 208
Medical Marijuana programs: Implications for cannabis control policy – Observations from Canada
Fischer, B., Kuganesan, S., & Room, R. (2015) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2014.09.007 · Cited by 86
Metadata
- Authors
- Reinarman, C., Nunberg, H., Lanthier, F., & Heddleston, T.
- Venue
- Journal of Psychoactive Drugs
- Publisher
- Informa UK Limited
- Published
- 2011-04
- Volume
- 43
- Issue
- 2
- Pages
- 128-135
- ISSN
- 0279-1072 (ISSN-L)
- 2159-9777
- OpenAlex
- W2027897070
- Cited by
- 290
- References
- 29
- FWCI
- 9.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.